Plus Therapeutics, Inc.
PSTV
$0.7691
-$0.075-8.89%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.44% | 10.72% | -98.38% | 32.13% | 32.66% |
| Total Depreciation and Amortization | 58.46% | 23.40% | 7.37% | -1.90% | -65.05% |
| Total Amortization of Deferred Charges | -100.00% | -100.00% | -92.45% | -75.76% | -62.50% |
| Total Other Non-Cash Items | -16.28% | -495.52% | -1,048.65% | 4.09% | 98.46% |
| Change in Net Operating Assets | 50.57% | -142.39% | 255.40% | -15.76% | -47.95% |
| Cash from Operations | 35.62% | -53.40% | 58.60% | 22.10% | 15.80% |
| Capital Expenditure | 73.81% | -40.00% | -636.36% | 58.76% | 67.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 252.38% | 10.00% | -34,463.64% | -275.26% | -281.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | -794.03% | 0.00% | 0.00% |
| Issuance of Common Stock | -100.00% | -100.00% | 433.02% | -- | -74.39% |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -102.74% |
| Cash from Financing | 100.00% | -100.00% | 624.56% | -257.40% | -634.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 53.22% | -3,423.42% | 210.01% | -4.74% | -14.26% |